{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:05:22Z","timestamp":1790413522306,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jcin.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T19:20:37Z","timestamp":1664392837000},"page":"2093-2102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-1072","authenticated-orcid":false,"given":"Sabine","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2704-3871","authenticated-orcid":false,"given":"Thomas","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Maiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"Euringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneliu","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Brechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Brucks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Langhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schellong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beschorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2022.08.004_bib1","first-page":"910","article-title":"Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2022.08.004_bib2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2022.08.004_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2022.08.004_bib4","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.08.004_bib5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-Year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.08.004_bib6","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.jcin.2018.07.041","article-title":"Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of 200 Chinese patients with severe femoropopliteal lesions: 24-month results of AcoArt I","volume":"11","author":"Xu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.08.004_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1148\/radiol.2020191619","article-title":"Drug-coated balloon angioplasty of femoropopliteal lesions maintained superior efficacy over conventional balloon: 2-year results of the randomized EffPac trial","volume":"295","author":"Teichgr\u00e4ber","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jcin.2022.08.004_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-year clinical outcomes of the CONSEQUENT trial: can femoropopliteal lesions be treated with sustainable clinical results that are economically sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2022.08.004_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2022.08.004_bib10","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehaa049","article-title":"COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions","volume":"41","author":"Steiner","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2022.08.004_bib11","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcin.2022.08.004_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1526602815626557","article-title":"Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability","volume":"23","author":"Katsanos","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2022.08.004_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","article-title":"Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease","volume":"70","author":"Caradu","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2022.08.004_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","article-title":"Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry","volume":"9","author":"Schmidt","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.08.004_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease","volume":"11","author":"Scheinert","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2022.08.004_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","article-title":"Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study","volume":"74","author":"Liistro","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2022.08.004_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2022.08.004_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2022.08.004_bib19","first-page":"CD006680","article-title":"Atherectomy for peripheral arterial disease","volume":"9","author":"Wardle","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcin.2022.08.004_bib20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized Disrupt PAD III trial","volume":"14","author":"Tepe","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.08.004_bib21","first-page":"197","article-title":"Mechanisms underlying drug delivery to peripheral arteries","volume":"6","author":"Li","year":"2017","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.jcin.2022.08.004_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11886-021-01477-4","article-title":"The safety of paclitaxel-coated devices for patients with peripheral artery disease","volume":"23","author":"Krawisz","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcin.2022.08.004_bib23","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2022.08.004_bib24","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jacc.2021.08.052","article-title":"Safety and effectiveness of paclitaxel drug-coated devices in peripheral artery revascularization: insights from VOYAGER PAD","volume":"78","author":"Hess","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2022.08.004_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcin.2022.01.290","article-title":"Femoropopliteal paclitaxel-eluting stents in the real world: does CAPSICUM add hot chili or sweet pepper?","volume":"15","author":"Thieme","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879822015473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879822015473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:16:51Z","timestamp":1761848211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879822015473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":25,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1936879822015473"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2022.08.004","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}